Ninlaro Positive In Non-Transplant MM Maintenance
Results To Pave Way For 'Bundled' Submission?
Executive Summary
Following a failure in a different indication earlier this year, positive top-line results show promise for Takeda proteasome inhibitor positive in first-line myeloma maintenance in non-transplant patients, setting the path for approval filings.